69 filings
Page 2 of 4
424B5
a1fytvmpe3qd0r55bh7f
4 Oct 23
Prospectus supplement for primary offering
4:05pm
8-K
velnuy uqp
2 Oct 23
Other Events
9:41pm
424B5
5kxqy4r
2 Oct 23
Prospectus supplement for primary offering
5:09pm
424B5
9sz9wnfff
2 Oct 23
Prospectus supplement for primary offering
5:07pm
S-3ASR
lv8xxfpwf2538ocxi8xj
2 Oct 23
Automatic shelf registration
4:01pm
8-K
ukfdxyi nx703j5g
27 Sep 23
Regulation FD Disclosure
6:58am
8-K
24dveyaa1tqkk5k8f49
31 Jul 23
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
4:29pm
8-K
7vav jr79ya2
28 Jul 23
Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate Updates
4:35pm
8-K
iqyj ab39r
31 May 23
Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day
7:03am
8-K
tku40gh19iq4jad
12 May 23
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
4:47pm
S-8
jui8c0
12 May 23
Registration of securities for employees
4:42pm
8-K
46urdw91 we
4 May 23
Departure of Directors or Certain Officers
5:15pm
8-K
dtrt7m1a98x jb
23 Mar 23
Investor Presentation March 2023
6:25pm
8-K
ohava68
23 Mar 23
Biohaven Reports Fourth Quarter and Full Year 2022 Financial Results and Reports Recent Business Developments
4:35pm
DEFA14A
jg003256
23 Mar 23
Additional proxy soliciting materials
4:30pm
DEF 14A
btptygwcklrwe3mr
23 Mar 23
Definitive proxy
4:27pm
10-K
bcs5j3n32
23 Mar 23
Annual report
4:17pm
8-K
y15ad3g81x17dvcm9bo
10 Jan 23
Regulation FD Disclosure
10:29am